Big Board Alerts

September 25, 2023
Valneva Announces New IXIARO Supply Contract with the U.S. Government Worth a Minimum of $32 Million

Valneva SE, a specialty vaccine company, today announced the signing of a new $32 million contract with the United States (U.S.) Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine, IXIARO.

Under this new one-year contract, the DoD will buy a minimum of $32 million worth of IXIARO vaccines and has the possibility to purchase additional doses during the coming twelve months. Deliveries will commence immediately.

Dipal Patel, Chief Commercial Officer of Valneva commented, “We are excited to continue our long-term relationship with the DoD. The U.S. military has trusted IXIARO for over ten years to help protect military personnel, their families, civilian government service personnel, and government contractors from this potentially deadly disease.”

IXIARO is the only JE vaccine approved by the U.S. Food and Drug Administration (FDA), having been developed through a cooperative research and development agreement with the Walter Reed Army Institute of Research. In the U.S., Valneva markets and distributes IXIARO directly to the military and private travel market.

The post Valneva Announces New IXIARO Supply Contract with the U.S. Government Worth a Minimum of $32 Million appeared first on Pharma Journalist.

 

Latest Articles

DON’T MISS THE OPPORTUNITY TO JOIN OUR MARKET SUMMARY REPORT FOR A LIMITED TIME

By submitting this form on our website, you agree that we may collect and use your personal information for marketing, and for other purposes as set forth in our privacy policy, which we encourage you to review.